Home›Stock Screener›Biopol Chemicals›Financial Statements

Biopol Chemicals Complete Financial Statements

3 Years of Data
2026 - 2024

In FY2026, Biopol Chemicals (BIOPOL) reported revenue ₹81 Cr, net profit ₹9 Cr and EPS ₹10.83, with a net profit margin of 11.1% and ROE of 18.0%. Full financial statements from FY2024 to FY2026 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Biopol Chemicals share price screener.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 11.11% 2026 data
EBITDA Margin 16.05% 2026 data
Operating Margin 17.00% 2026 data
Return on Assets 12.86% 2026 data
Return on Equity 18.00% 2026 data

Balance Sheet Ratios

Current Ratio 11.00 2026 data
Equity Ratio 71.43% 2026 data
Asset Turnover 1.16 2026 data

BIOPOL Revenue, Net Profit & EBITDA — Year-on-Year Growth

BIOPOL YoY (March 2025 vs March 2026) — revenue +65.3%, net profit +125.0%, EBITDA +85.7%, expenses +58.1%. Explore Biopol Chemicals intrinsic worth to estimate fundamental worth using multiple valuation models.

Revenue Growth
+65.3%
Year-over-Year
Net Profit Growth
+125.0%
Year-over-Year
EBITDA Growth
+85.7%
Year-over-Year
Expense Growth
+58.1%
Year-over-Year
Assets Growth
+118.8%
Year-over-Year
Equity Growth
+257.1%
Year-over-Year
Operating Cash Flow Growth
+66.7%
Year-over-Year
Investing Cash Flow Growth
+100.0%
Year-over-Year
Financing Cash Flow Growth
-57.1%
Year-over-Year

BIOPOL Income Statement — Revenue, EBITDA & Net Profit

Biopol Chemicals revenue ₹81 Cr, EBITDA ₹13 Cr, net profit ₹9 Cr, EPS ₹10.83 (2026) — net profit margin 11.1%. Review Biopol Chemicals P/E valuation to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024
Revenue 81 49 26
Expenses 68 43 21
EBITDA 13 7 4
Operating Profit Margin % 17.00% 13.00% 17.00%
Depreciation 0 0 0
Interest 2 1 0
Profit Before Tax 12 6 4
Tax 3 2 1
Net Profit 9 4 3
Earnings Per Share (₹) 10.83 5.49 3.75

BIOPOL Balance Sheet — Assets, Liabilities & Shareholders' Equity

BIOPOL total assets ₹70 Cr, total equity ₹50 Cr, total liabilities ₹ Cr (2026) — ROE 18.0%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024
ASSETS
Total Assets 70 32 18
Current Assets 55 31 17
Fixed Assets 14 0 0
Capital Work in Progress 0 0 0
Investments 20 0 0
Other Assets 0 31 17
LIABILITIES
Total Liabilities
Current Liabilities 5 1 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 50 14 9
Share Capital 11 8 8
Reserves & Surplus 39 6 1

BIOPOL Cash Flow Statement — Operating, Investing & Financing

Biopol Chemicals operating cash flow ₹-2 Cr, investing ₹0 Cr, financing ₹3 Cr, net cash flow ₹1 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024
Operating Activities -2 -6
Investing Activities 0 -1
Financing Activities 3 7
Net Cash Flow 1 0